The last of three historically bullish crypto events is expected to happen around April 14. It's only the fourth time in crypto history. The last time, in 2020, certain altcoins exploded. Some as high as 531,735% or even a 953,018% gain. A tiny $100 investment would have returned just short of a million dollars. Here's what our expert says you should buy before April 14
OpenAI co-founder Sam Altman showered praise on Apple Vision Pro, calling it the second most impressive technology since the iPhone. Continue Reading ➔
Some are calling this the most promising DeFi project since Ethereum itself. Here's the #1 DeFi Coin Set to Soar. While Bitcoin grabs headlines, this lesser known DeFi coin is quietly gearing up for a monster rally. Experts say now is the time to buy before it reaches escape velocity. Discover our top DeFi pick
WASHINGTON (AP) — Just a quarter of business economists and analysts expect the United States to fall into recession this year. And any downturn would likely result from an external shock – such as a conflict involving China – rather than from domestic economic factors such as higher interest rates. Continue Reading ➔
What does it mean when an option position is in-the-money? Out-of-the-money? At-the-money? The live OIC webinar on February 14, 2024 will answer that question by focusing on the basics of options pricing. Click here to attend
Alina Habba, legal counsel for Donald Trump, was seen at a party, despite having pleaded illness to postpone the former president's defamation trial. Continue Reading ➔
Cramer, on Monday, analyzed the recent comments made by Federal Reserve Chairman Jerome Powell regarding inflation. Despite the uncertainty about the timing of the rate cuts, Cramer believes there are profit opportunities. Continue Reading ➔
Don't let market volatility erode your hard-earned savings. Our free gold guide shows you how to turn your 401k into a gold IRA and protect your retirement today. Download your free gold guide now
A federal judge has instructed Elon Musk to testify once more in the U.S. Securities and Exchange Commission's investigation into his $44 billion acquisition of Twitter. Both the regulator and Musk have been given a week to agree on the date and location for the interview. Continue Reading ➔
UBS bank predicts it will become "The Biggest Drug Ever." Morgan Stanley predicts 250 million prescriptions will be written each year. It's set for FDA approval in the next 90 days. We believe an FDA approval could send shares soaring 678%. Get the name of the stock here
Recent reports indicate that FBI agents may have overlooked a "hidden room" and a closet at former President Donald Trump's Mar-a-Lago estate during their search for classified documents. Continue Reading ➔
At a campaign event in Conway, South Carolina, on Saturday, former President Donald Trump, who is eyeing the presidency in 2024 as the Republican frontrunner, said that he would encourage Russia Continue Reading ➔
Armenian Prime Minister Nikol Pashinyan made it clear that Armenia is not an ally of Russia in its conflict with Ukraine. He also emphasized that Armenia's military projects are not aimed at any specific nation. Continue Reading ➔
NEW YORK (AP) — A Russian billionaire art collector lost a legal fight with Sotheby’s on Tuesday, when a U.S. jury sided with the auction house in a lawsuit over while assembling a trove of works that included a Continue Reading ➔
Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.
